Cavex Holland BV – Trademark Portfolio

Entity Type: 03

Cavex Holland BV holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CAVEX. The owner is based in 2003 RW Haarlem.

Harmenjansweg 19-21

2003 RW Haarlem , NL

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CAVEX
CAVEX
Registered 2001
RAINBOW
RAINBOW
Abandoned 1999
QUADRANT
QUADRANT
Cancelled 1998

Trademark Classifications

Cavex Holland BV's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Cavex Holland BV have?

Cavex Holland BV has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Cavex Holland BV file in?

Cavex Holland BV files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Cavex Holland BV's most well-known trademarks?

Cavex Holland BV's registered trademark portfolio includes well-known marks such as CAVEX. These are among 1 currently registered trademark in the portfolio.

What is Cavex Holland BV's trademark registration success rate?

Cavex Holland BV has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.